TrialWorld journal of urology2026
Intermediate-term oncological and functional outcomes of neoadjuvant 177-Lu-PSMA-I&T radionuclide treatment followed by radical prostatectomy.
Michael Frumer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.